Simplifying Global Compliance
FDAnews Device Daily Bulletin
Medical Devices / Commercial Operations
Nichi-Iko Picks Up Sagent Pharmaceuticals
July 18, 2016
Nichi-Iko Pharmaceutical has entered into an agreement to acquire Sagent Pharmaceuticals for nearly $736 million.
The acquisition combines Nichi-Iko’s biosimilar portfolio and Sagent’s line of injectables.
Currently, no operational changes are expected for Sagent Pharmaceuticals. — Anisa Jibrell
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing